25 years of maturation: A systematic review of RNAi in the clinic

Molecular Therapy-Nucleic Acids - cell.com
The year 2023 marks the 25 th anniversary of the discovery of RNA interference (RNAi).
RNAi-based therapeutics enable sequence-specific gene knockdown by eliminating target …

[HTML][HTML] 25 years of maturation: A systematic review of RNAi in the clinic

IJ Corydon, BK Fabian-Jessing… - Molecular Therapy …, 2023 - ncbi.nlm.nih.gov
The year 2023 marks the 25th anniversary of the discovery of RNAi. RNAi-based
therapeutics enable sequence-specific gene knockdown by eliminating target RNA …

[HTML][HTML] 25 years of maturation: A systematic review of RNAi in the clinic

IJ Corydon, BK Fabian-Jessing, TS Jakobsen… - … Therapy-Nucleic Acids, 2023 - Elsevier
The year 2023 marks the 25th anniversary of the discovery of RNAi. RNAi-based
therapeutics enable sequence-specific gene knockdown by eliminating target RNA …

25 years of maturation: A systematic review of RNAi in the clinic.

IJ Corydon, BK Fabian-Jessing… - Molecular therapy …, 2023 - europepmc.org
The year 2023 marks the 25th anniversary of the discovery of RNAi. RNAi-based
therapeutics enable sequence-specific gene knockdown by eliminating target RNA …

25 years of maturation: A systematic review of RNAi in the clinic

IJ Corydon, BK Fabian-Jessing, TS Jakobsen… - … Therapy-Nucleic Acids, 2023 - pure.au.dk
The year 2023 marks the 25th anniversary of the discovery of RNAi. RNAi-based
therapeutics enable sequence-specific gene knockdown by eliminating target RNA …

25 years of maturation: A systematic review of RNAi in the clinic

IJ Corydon, BK Fabian-Jessing… - Molecular therapy …, 2023 - pubmed.ncbi.nlm.nih.gov
The year 2023 marks the 25th anniversary of the discovery of RNAi. RNAi-based
therapeutics enable sequence-specific gene knockdown by eliminating target RNA …

[引用][C] 25 years of maturation: A systematic review of RNAi in the clinic

IJ Corydon, BK Fabian-Jessing, TS Jakobsen… - europepmc.org
The year 2023 marks the 25th anniversary of the discovery of RNAi. RNAi-based
therapeutics enable sequence-specific gene knockdown by eliminating target RNA …